Table of Contents Author Guidelines Submit a Manuscript
Research Article

Treatment Discontinuation and Clinical Events in Type 2 Diabetes Patients Treated with Dipeptidyl Peptidase-4 Inhibitors or NPH Insulin as Third-Line Therapy

Received 6 September 2017; Accepted 21 January 2018

Academic Editor: Jordi Lluis Reverter